IGF1 and cancer: Because of the IGF-I's mitotic properties, lower levels of IGFBP-3, by increasing the IGF-I/IGFBP-3 ratio, may increase the risk of developing cancer, with the opposite occurring when tissue availability of IGF-I is reduced.